(IBTJ) iShares iBonds Dec 2029 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E8259
IBTJ: U.S. Treasury Securities, Target Maturity ETF
The iShares iBonds Dec2029 Term Treasury ETF (NASDAQ:IBTJ) is a target maturity ETF that focuses on investing in U.S. Treasury securities with maturities between January 1, 2029, and December 15, 2029. By concentrating on a specific maturity period, the fund provides investors with a predictable income stream and reduced exposure to interest rate risk.
To achieve its investment objective, the fund will allocate at least 80% of its assets to the component securities of the underlying index, ensuring a high degree of tracking accuracy. Furthermore, the fund will invest at least 90% of its assets in U.S. Treasury securities, which are generally considered to be low-risk investments. This allocation strategy enables the fund to maintain a high level of credit quality and minimize the risk of default.
With an AUM of $677.96 million, the fund has achieved a respectable size, indicating a moderate level of investor interest. The ETFs liquidity profile, as indicated by its ATR of 0.06 (0.29%), suggests that it is relatively stable and not subject to extreme price movements.
From a technical analysis perspective, the funds price is currently at $21.86, above its SMA20, SMA50, and SMA200, indicating a positive trend. The 52-week high and low prices of $21.86 and $20.48, respectively, suggest that the fund has experienced a relatively stable price range over the past year. Based on the current technical indicators, it is likely that the fund will continue to trade within a narrow range, potentially consolidating around the $21.70 level.
Forecasting the funds future performance, we can expect the IBTJ to continue to be influenced by the overall direction of interest rates and the yield curve. As the fund is heavily invested in U.S. Treasury securities, changes in monetary policy and economic indicators will likely impact its price. Assuming a stable interest rate environment, the fund is likely to continue to trade within a narrow range, potentially reaching $22.10 by the end of 2029, as it approaches maturity and the constituent securities are redeemed.
Additional Sources for IBTJ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IBTJ ETF Overview
Market Cap in USD | 678m |
Category | Target Maturity |
TER | 0.07% |
IPO / Inception | 2020-02-25 |
IBTJ ETF Ratings
Growth Rating | -10.2 |
Fundamental | - |
Dividend Rating | 73.8 |
Rel. Strength | -7.09 |
Analysts | - |
Fair Price Momentum | 21.81 USD |
Fair Price DCF | - |
IBTJ Dividends
Dividend Yield 12m | 3.90% |
Yield on Cost 5y | 3.55% |
Annual Growth 5y | 39.53% |
Payout Consistency | 100.0% |
Payout Ratio | % |
IBTJ Growth Ratios
Growth Correlation 3m | 44.7% |
Growth Correlation 12m | 65.1% |
Growth Correlation 5y | -54.5% |
CAGR 5y | -1.56% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | 0.39 |
Alpha | 2.63 |
Beta | -0.051 |
Volatility | 3.73% |
Current Volume | 94.6k |
Average Volume 20d | 108.9k |
As of June 29, 2025, the stock is trading at USD 21.89 with a total of 94,589 shares traded.
Over the past week, the price has changed by +0.53%, over one month by +1.12%, over three months by +2.09% and over the past year by +6.33%.
Neither. Based on ValueRay´s Analyses, iShares iBonds Dec 2029 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -10.24 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTJ is around 21.81 USD . This means that IBTJ is currently overvalued and has a potential downside of -0.37%.
iShares iBonds Dec 2029 has no consensus analysts rating.
According to our own proprietary Forecast Model, IBTJ iShares iBonds Dec 2029 will be worth about 23.6 in June 2026. The stock is currently trading at 21.89. This means that the stock has a potential upside of +7.63%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 23.6 | 7.6% |